Stock Monitor: Dollar General Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free earnings report on Wal-Mart Stores, Inc. (NYSE: WMT) (“Walmart”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=WMT. Wal-Mart reported its third quarter fiscal 2018 operating results on November 16, 2017. The Company’s same-store sales (comp) for its US locations climbed for the 13th consecutive quarter. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Dollar General Corporation (NYSE: DG), which also belongs to the Services sector as the Company Wal-Mart Stores. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=DG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Wal-Mart Stores most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=WMT

Earnings Highlights and Summary

For the thirteen-week ended October 27, 2017, Walmart’s total revenue grew 4.2% to $123.18 billion compared to $118.18 billion in Q3 FY17. Excluding currency, the Company’s total revenue was $122.7 billion, reflecting an increase of 3.8%. Walmart’s revenue numbers surpassed analysts’ expectations of $121 billion.

For Q3 FY18, Walmart’s net income totaled $1.75 billion, or $0.58 per diluted share, compared to net income of $3.03 billion, or $0.98 per diluted share, in Q3 FY17. On an adjusted basis, the Company reported EPS of $1.00 per share, ahead of Wall street’s estimates of $0.97 per share.

Walmart’s reported quarter GAAP EPS was adjusted for a charge of $0.29 for loss on extinguishment of debt in connection with the Company’s recently completed debt tender offer, a charge of $0.09 based on discussions with government agencies regarding the possible resolution of the FCPA matter, and a charge of $0.04 based on the decision to exit certain properties in one of Walmart’s international markets

Walmart’s Segment Results

During Q3 FY18, the US segment’s net sales increased 4.3% to $77.72 billion on a y-o-y basis. The segment’s comp sales grew 2.7% led by a strong comp traffic of 1.5%. Ecommerce contributed approximately 80 basis points to the segment’s comp sales growth. Hurricane-related impacts benefited comp sales by approximately 30-50 basis points.

Walmart US’s gross margin rate declined 36 basis points in Q3 FY18. The margin rate was pressured by the continued execution of the Company’s price investment strategy and the mix effects from its growing ecommerce business. This segment’s operating expenses leveraged 10 basis points, despite hurricane-related expenses. Physical stores leveraged expenses for the 3rd consecutive quarter and were partially offset by investments in ecommerce and technology.

Walmart US opened 2 supercenters and 2 neighborhood markets in Q3 FY18. The Company also remodeled 208 stores. As of the end of the reported quarter, Wal-Mart US offered online grocery in over 1,100 locations, which represents more than 200 additional locations since Q2 FY18.

For Q3 FY18, net sales at Walmart International were $29.5 billion, reflecting an increase of 4.1%. Excluding currency, the segment’s net sales totaled $29.1billion, an increase of 2.5% on a y-o-y basis. In the reported quarter, ten of eleven markets posted positive comp sales, including Walmart’s four largest markets.

The International segment’s gross margin rate declined 18 basis points, primarily driven by planned price investments in certain markets. The segment’s operating income declined 12.2% on a constant currency basis and 7.8% on a reported basis. The drop in operating income was attributed to the ~$150 million impairment related to Company’s decision to exit certain properties in one of its markets as well as lapping last year’s gain of $86 million from the sale of several shopping malls in Chile.

Cash Matters

Walmart reported net cash provided by operating activities of $17.1 billion and $19.8 billion for the nine months ended October 31, 2017 and 2016, respectively. The Company generated free cash flow of $10.2 billion and $12.3 billion for the nine months ended October 31, 2017 and 2016, respectively. The decreases in net cash provided by operating activities and free cash flow in FY18 were due to the timing of payments and an increase in incentive payments as well as lapping prior year’s improvements in working capital management.

Wal-Mart’s Return on Assets (ROA) was 5.8% and 7.3% for the trailing twelve months ended October 31, 2017 and 2016, respectively, while Return on Investment (ROI) was 14.7% and 15.0% for the trailing twelve months ended October 31, 2017 and 2016, respectively. The decline in ROA was primarily due to the loss on extinguishment of debt and the decrease in operating income. The decline in ROI was primarily due to the decrease in operating income.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, Wal-Mart Stores’ stock marginally climbed 0.10%, ending the trading session at $99.26.

Volume traded for the day: 4.89 million shares.

Stock performance in the last month – up 2.73%; previous three-month period – up 25.19%; past twelve-month period – up 42.41%; and year-to-date – up 43.61%

After yesterday’s close, Wal-Mart Stores’ market cap was at $293.60 billion.

Price to Earnings (P/E) ratio was at 26.39.

The stock has a dividend yield of 2.06%.

The stock is part of the Services sector, categorized under the Discount, Variety Stores industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485060

Stock Monitor: Ascena Retail Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free earnings report on L Brands, Inc. (NYSE: LB). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=LB. The Company posted its third quarter fiscal 2017 operating results on December 01, 2017. The leading lingerie and personal care products manufacturer’s Bath & Body Works comparable store sales rose approximately 1.00% in the reported quarter. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Ascena Retail Group, Inc. (NASDAQ: ASNA), which also belongs to the Services sector as the Company L Brands. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=ASNA

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, L Brands most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=LB

Earnings Highlights and Summary

In Q3 FY17, L Brands posted revenues of $2.62 billion compared to $2.58 billion in Q3 FY16, advancing 1.43% on a y-o-y basis. The Company’s revenue numbers beat analysts’ estimates of $2.61 billion.

The Company posted a gross profit of $989.00 million in the reported quarter compared to $1.03 billion in Q3 FY16, declining 3.51% on a y-o-y basis. L Brands posted general, administrative, and store operating expenses of $757.00 million in the reported quarter compared to $741.00 million in Q3 FY16.

L Brands’ operating income was $232.00 million in Q3 FY17 compared to $284.00 million in Q3 FY16, decreasing 18.31% on a y-o-y basis.

The Company had a net income of $86.00 million in Q3 FY17 compared to $122.00 million in Q3 FY16, showing a decline of 29.51% on a y-o-y basis. The diluted earnings per share (EPS) declined 28.57% to $0.30 in the reported quarter compared to $0.42 in Q3 FY16, meeting analysts’ expectations.

Segment Details

L Brands has three reportable segments, namely: (i) Victoria’s Secret, (ii) Bath & Body Works, and (iii) Victoria’s Secret and Bath and Body Works International.

In Q3 FY17, Victoria’s Secret had net sales of $1.54 billion compared to $1.58 billion in Q3 FY16, declining 2.84% on a y-o-y basis, due to low-single digits fall in lingerie bra sales. The segment’s operating income was $134.00 million in Q3 FY17 compared to $164.00 million in Q3 FY16, decreasing 18.29% on a y-o-y basis.

Bath & Body Works segment had revenues of $816.00 million in Q3 FY17 compared to $770.00 million in Q3 FY16, reflecting a growth of 5.97% on a y-o-y basis, due to a strong performance by home assortment sub-segment. The segment’s operating income was $138.00 million in Q3 FY17 compared to $145.00 million in Q3 FY16, declining 4.83% on a y-o-y basis.

Victoria’s Secret and Bath & Body Works International segment had revenues of $115.00 million in Q3 FY17 compared to $104.00 million in Q3 FY16, rising 10.58% on a y-o-y basis.

Cash Matters

L Brands had cash and cash equivalents of $735.00 million on October 28, 2017, compared to $654.00 million on October 29, 2016. The Company’s cash inflow from operating activities was $138.00 million on October 28, 2017, compared to $411.00 million on October 29, 2016. On October 28, 2017, L Brands’ capital expenditure was $599.00 million compared to $825.00 million on October 29, 2017. In Q3 FY17, the Company’s Board of Directors approved a new $250.00 million share repurchase program, inclusive of the $10.00 million remaining under the February 2017 repurchase program. In September 2017, L Brands repurchased 935,000 shares at an average price of $41.30 per share, for a total consideration of $38.62 million. On November 10, 2017, the Company declared a quarterly dividend of $0.60 per share, payable on December 08, 2017, to shareholders of record at the close of business on November 24, 2017.

Outlook

For Q4 FY17, L Brands anticipates EPS to be in the range of $1.95 – $2.10, while for the fiscal year 2017, the Company expects EPS to be in the band of $3.05 – $3.20.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, L Brands’ stock fell 2.70%, ending the trading session at $61.25.

Volume traded for the day: 1.93 million shares.

Stock performance in the last month – up 21.67%; previous three-month period – up 43.24%; and past six-month period – up 12.88%

After yesterday’s close, L Brands’ market cap was at $17.07 billion.

Price to Earnings (P/E) ratio was at 18.67.

The stock has a dividend yield of 3.92%.

The stock is part of the Services sector, categorized under the Apparel Stores industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485055

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free earnings report on Spire Inc. (NYSE: SR). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=SR. The Company posted its financial results on November 14, 2017, for the fourth quarter and for the fiscal year 2017. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Spire most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=SR

Earnings Highlights and Summary

For the three months ended September 29, 2017, Spire’s total operating revenue decreased 7.4% to $258.7 million from $279.3 million in Q4 FY16. The Company’s revenue numbers were below analysts’ expectations of $278.73 million.

During FY17, the Company’s revenue increased 13.2% to $1.74 billion from $1.54 billion in FY16.

During Q4 FY17, Spire’s operating income was $1.90 million compared to an operating loss of $7.7 million in the same period of last year.

During FY17, the Company’s operating income increased 14% to $321.7 million from $282.3 million in FY16. During FY17, the Company’s operating margin increased 10 basis points to 18.5% of revenue from 18.4% of revenue in FY16.

During Q4 FY17, Spire’s earnings before tax (EBT) was negative $20.0 million versus negative $22.4 million in the comparable period of last year.

For the reported quarter, Spire’s net loss was $13.3 million compared to a net loss of $14.2 million in Q4 FY16. During Q4 FY17, the Company’s diluted earnings per share (EPS) was negative $0.28 compared to negative $0.31 in the corresponding period of last year. For the reported quarter, Spire’s adjusted net loss was $10.5 million compared to an adjusted net loss of $14.1 million in Q4 FY16. During Q4 FY17, the Company’s adjusted diluted EPS was negative $0.22 compared to negative $0.32 in Q4 FY16, surpassing analysts’ expectations of negative $0.26.

During FY17, the Company’s net income increased 12.1% to $161.6 million from $144.2 million in FY16. During FY17, the Company’s diluted EPS increased 5.9% to $3.43 from $3.24 in FY16.

Segment Details

Gas Utility – During Q4 FY17, the Company’s Gas Utility segment’s revenue increased 24.4% to $240.9 million from $193.7 million in the same period of last year. For the reported quarter, the segment’s operating income was $1.3 million compared to an operating loss of $11.8 million in Q4 FY16. For the reported quarter, the segment’s contribution margin increased 15.2% to $161.2 million from $139.9 million in Q4 FY16. For the reported quarter, the segment’s net economic earnings (NEE) was negative $5.8 million compared to negative $10.2 million in Q4 FY16.

Gas Marketing – During Q4 FY17, the Company’s Gas Marketing segment’s revenue decreased 68.4% to $17.5 million from $55.4 million in the comparable period of last year. For the reported quarter, the segment’s operating income decreased 67.6% to $2.3 million from $7.1 million in Q4 FY16. For the reported quarter, the segment’s contribution margin decreased 53.5% to $4.0 million from $8.6 million in Q4 FY16. For the reported quarter, the segment’s net economic earnings (NEE) increased 63.2% to $3.1 million from $1.9 million in Q4 FY16.

Balance Sheet

As on September 29, 2017, Spire’s cash and cash equivalents increased 42.3% to $7.4 million from $5.2 million as on September 30, 2016. For the reported quarter, the Company’s long-term debt increased 9.6% to $2.00 billion from $1.82 billion in Q4 FY16.

For the reported quarter, the Company’s net accounts receivable increased 23% to $271.4 million from $220.7 million in Q4 FY16. For the reported quarter, the Company’s accounts payable increased 21.9% to $257.1 million from $210.9 million in Q4 FY16.

During FY17, the Company’s net cash provided by operating activities decreased 12.2% to $288.3 million from $328.3 million in FY16.

On November 14, 2017, the Company’s Board of Directors declared a quarterly dividend of $2.25 per share payable on January 03, 2018, to shareholders of record on December 11, 2017.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, Spire’s stock advanced 1.02%, ending the trading session at $74.50.

Volume traded for the day: 138.23 thousand shares.

Stock performance in the previous six-month period – up 6.58%; past twelve-month period – up 14.97%; and year-to-date – up 15.41%

After yesterday’s close, Spire’s market cap was at $3.58 billion.

Price to Earnings (P/E) ratio was at 21.18.

The stock has a dividend yield of 3.02%.

The stock is part of the Utilities sector, categorized under the Gas Utilities industry. This sector was up 0.5% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485056

Stock Monitor: Pure Storage Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free earnings report on NetApp, Inc. (NASDAQ: NTAP). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=NTAP. The Company posted its financial results on November 15, 2017, for the second quarter of the fiscal year 2018. The storage and data management Company’s revenue and adjusted EPS surpassed analysts’ expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Pure Storage, Inc. (NYSE: PSTG), which also belongs to the Technology sector as the Company NetApp. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=PSTG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, NetApp most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=NTAP

Earnings Highlights and Summary

For the three months ended October 27, 2017, NetApp’s net revenues increased 6% to 1.42 billion from $1.34 billion in Q2 FY17. The Company’s net revenues surpassed analysts’ expectations of $1.38 billion.

During Q2 FY18, NetApp’s gross profit increased 8.8% to $902 million from $829 million in the same period of last year. For the reported quarter, the Company’s gross margin increased 150 basis points to 63.4% of revenue from 61.9% of revenue in Q2 FY17. For the reported quarter, the Company’s adjusted gross margin increased 160 basis points to 64.3% of revenue from 62.7% of revenue in Q2 FY17.

During Q2 FY18, NetApp’s operating income increased 54.2% to $219 million from $142 million in the comparable period of last year. For the reported quarter, the Company’s operating margin increased 480 basis points to 15.4% of revenue from 10.6% of revenue in Q2 FY17. For the reported quarter, the Company’s adjusted operating margin increased 390 basis points to 19.1% of revenue from 15.2% of revenue in Q2 FY17.

During Q2 FY18, NetApp’s earnings before tax (EBT) increased 58.5% to $225 million from $142 million in the corresponding period of last year. For the reported quarter, the Company’s EBT margin increased 520 basis points to 15.8% of revenue from 10.6% of revenue in Q2 FY17.

For the reported quarter, NetApp’s net income increased 60.6% to $175 million on a y-o-y basis from $109 million in Q2 FY17. During Q2 FY18, the Company’s diluted earnings per share (EPS) increased 68.4% to $0.64 on a y-o-y basis from $0.38 in the same period of last year. For the reported quarter, NetApp’s adjusted net income increased 32% to $223 million on a y-o-y basis from $169 million in Q2 FY17. During Q2 FY18, the Company’s adjusted diluted EPS increased 35% to $0.81 on a y-o-y basis from $0.60 in Q2 FY17, surpassing analysts’ expectations of $0.69.

Segment Details

Product – During Q2 FY18, the Company’s Product segment’s revenue increased 13.7% to $807 million from $710 million in the comparable period of last year. For the reported quarter, the segment’s gross profit increased 22.2% to $408 million from $334 million in Q2 FY17. For the reported quarter, the segment’s adjusted gross margin increased 360 basis points to 51.8% of revenue from 48.2% of revenue in Q2 FY17.

Software Maintenance – During Q2 FY18, the Company’s Software Maintenance segment’s revenue decreased 0.8% to $240 million from $242 million in the corresponding period of last year. For the reported quarter, the segment’s gross profit decreased 0.4% to $234 million from $235 million in Q2 FY17. For the reported quarter, the segment’s adjusted gross margin increased 40 basis points to 97.5% of revenue from 97.1% of revenue in Q2 FY17.

Hardware Maintenance and Other Services – During Q2 FY18, the Company’s Hardware Maintenance and Other Services segment’s revenue decreased 3.4% to $375 million from $388 million in the same period of last year. For the reported quarter, the segment’s gross profit was on par with the $260 million recorded in Q2 FY17. For the reported quarter, the segment’s adjusted gross margin increased 210 basis points to 69.9% of revenue from 67.8% of revenue in Q2 FY17.

Balance Sheet

As on October 27, 2017, NetApp’s cash, cash equivalents, and investments increased 21.2% to $5.97 billion from $4.92 billion as on April 28, 2017. For the reported quarter, the Company’s long-term debt increased 107% to $1.54 billion from $744 million in Q4 FY17.

For the reported quarter, the Company’s accounts receivable decreased 20.1% to $584 million from $731 million in Q4 FY17. For the reported quarter, the Company’s accounts payable increased 9.2% to $379 million from $347 million in Q4 FY17.

During Q2 FY18, the Company’s net cash provided by operating activities increased 98.7% to $314 million from $158 million in the comparable period of last year. During Q2 FY18, the Company’s free cash flow increased 179.4% to $285 million from $102 million in Q2 FY17.

Outlook

For Q3 FY18, the Company expects revenue to be in the range of $1.43 billion – $1.58 billion. The Company estimates diluted EPS to be in the band of $1.18 – $1.26, and adjusted diluted EPS to be in the range of $0.86 – $0.94 for Q3 FY18.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, NetApp’s stock slightly climbed 0.52%, ending the trading session at $56.15.

Volume traded for the day: 971.35 thousand shares.

Stock performance in the last three-month – up 27.12%; previous six-month period – up 38.95%; past twelve-month period – up 53.37%; and year-to-date – up 59.20%

After yesterday’s close, NetApp’s market cap was at $15.10 billion.

Price to Earnings (P/E) ratio was at 24.11.

The stock has a dividend yield of 1.42%.

The stock is part of the Technology sector, categorized under the Data Storage Devices industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485057

Stock Monitor: Finish Line Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free earnings report on Sally Beauty Holdings, Inc. (NYSE: SBH) (“Sally Beauty”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=SBH. The Company posted its financial results on November 15, 2017, for the fourth quarter of the fiscal year 2017. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for The Finish Line, Inc. (NASDAQ: FINL), which also belongs to the Services sector as the Company Sally Beauty. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=FINL

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Sally Beauty Holdings most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=SBH

Earnings Highlights and Summary

For the three months ended September 30, 2017, Sally Beauty’s net revenue decreased 0.2% to $974.20 million from $976.36 million in Q4 FY16. The Company’s net revenue numbers were below analysts’ expectations of $989.97 million.

As on September 30, 2017, the Company had 5,150 stores compared to 5,119 stores as on September 30, 2016. For the reported quarter, the Company’s same store sales growth was negative 1.4% compared to positive 1.2% in the fourth quarter of 2016.

During Q4 FY17, Sally Beauty’s gross profit decreased 0.2% to $482.44 million from $483.44 million in the same period of last year. For the reported quarter, the Company’s gross margin was on par with the 49.5% of revenue recorded in Q4 FY16.

During Q4 FY17, Sally Beauty’s earnings before interest, tax, depreciation, and amortization (EBITDA) increased 1.6% to $140.12 million from $137.95 million in the comparable period of last year. During Q4 FY17, Sally Beauty’s adjusted EBITDA decreased 1.8% to $150.45 million from $153.20 million in Q4 FY16. For the reported quarter, the Company’s adjusted EBITDA margin decreased 30 basis points to 15.4% of revenue from 15.7% of revenue in Q4 FY16.

During Q4 FY17, Sally Beauty’s operating income increased 0.9% to $111.76 million from $110.82 million in the corresponding period of last year. For the reported quarter, the Company’s operating margin increased 10 basis points to 11.5% of revenue from 11.4% of revenue in Q4 FY16. For the reported quarter, the Company’s adjusted operating margin decreased 30 basis points to 12.3% of revenue from 12.6% of revenue in Q4 FY16.

During Q4 FY17, Sally Beauty’s earnings before tax (EBT) decreased 29.4% to $59.48 million from $84.20 million in the same period of last year. For the reported quarter, the Company’s EBT margin decreased 250 basis points to 6.1% of revenue from 8.6% of revenue in Q4 FY16.

For the reported quarter, Sally Beauty’s net income decreased 32.1% to $35.72 million from $52.62 million in Q4 FY16. During Q4 FY17, the Company’s diluted earnings per share (EPS) decreased 25% to $0.27 from $0.36 in the comparable period of last year. For the reported quarter, Sally Beauty’s adjusted net income decreased 2.4% to $59.04 million from $60.48 million in Q4 FY16. During Q4 FY17, the Company’s adjusted diluted EPS increased 9.8% to $0.45 on a y-o-y basis from $0.41 in Q4 FY16. The adjusted diluted EPS was below analysts’ expectations of $0.47.

Segment Details

Sally Beauty Supply (SBS) – During Q4 FY17, the Company’s SBS segment’s net revenue decreased 0.8% to $584.38 million from $589.27 million in the corresponding period of last year. For the reported quarter, the segment’s gross margin increased 10 basis points to 55.1% of revenue from 55.0% of revenue in Q4 FY16. For the reported quarter, the segment’s operating margin decreased 100 basis points to 15.6% of revenue from 16.6% of revenue in Q4 FY16.

Beauty Systems Group (BSG) – During Q4 FY17, the Company’s BSG segment’s net revenue increased 0.7% to $389.81 million from $387.09 million in the same period of last year. For the reported quarter, the segment’s gross margin increased 10 basis points to 41.2% of revenue from 41.1% of revenue in Q4 FY16. For the reported quarter, the segment’s operating margin was on par with the 15.7% of revenue recorded in Q4 FY16.

Balance Sheet

As on September 30, 2017, Sally Beauty’s cash and cash equivalents decreased 26.4% to $63.76 million from $86.62 million as on September 30, 2016. For the reported quarter, the Company’s long-term debt, including capital leases, decreased 0.6% to $1.77 billion from $1.78 billion in Q4 FY16.

For the reported quarter, the Company’s trade and other accounts receivables increased 9.8% to $92.24 million from $83.98 million in Q4 FY16. For the reported quarter, the Company’s accounts payable increased 13.4% to $307.75 million from $271.38 million in Q4 FY16.

During Q4 FY17, the Company’s net cash provided by operating activities increased 18.4% to $120.96 million from $102.19 million in the comparable period of last year. During Q4 FY17, the Company’s operating free cash flow increased 58.4% to $97.87 million from $61.77 million in Q4 FY16.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, Sally Beauty Holdings’ stock was slightly down 0.86%, ending the trading session at $18.55.

Volume traded for the day: 924.48 thousand shares.

Stock performance in the last month – up 16.30%

After yesterday’s close, Sally Beauty Holdings’ market cap was at $2.42 billion.

Price to Earnings (P/E) ratio was at 11.97.

The stock is part of the Services sector, categorized under the Specialty Retail, Other industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485058

– Biotricity’s (BTCY) New Medical Device Bioflux Now USFDA Cleared and Ready for Commercial Launch; Company Has Key Components in Place for Successful Sales Effort, Including Financing and Probable Insurance & Medicare Reimbursement
– Comparable Cardio Monitoring Company Biotelemetry (BEAT) Worth $1 Billion in Market Value, Suggesting Huge Upside Possible for BTCY as Company Enters Unsaturated Space with Attractive and Possibly Disruptive Product and Unique Commercial Strategy to Win Over Physicians
– Buildout of Additional Remote Biometric Monitoring Devices in 2018 and 2019 into Full Portfolio Offering Could Make BTCY Worth Multiples of Today’s Prices

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / With their novel Bioflux MCT device just USFDA cleared days ago and a financing out of the way, Biotricity (BTCY) has all of the pieces in place for a successful launch of this new cardiac monitoring device into a $22 billion market. Unlike many other medical devices that reach FDA clearance, Biotricity has many of the facets already in place for strong commercialization in 2018, like reimbursement procedures for insurance providers & Medicare, and a unique marketing strategy.

A similar public company BioTelemetry (BEAT) is already valued at $1 Billion by the public markets just a few years into launching their own suite of cardiotelemetry devices, indicating that BTCY could be in for a huge 2018 and 2019 as they move from development to revenue-generation. It’s a hot sector, and the company plans to build out a suite of high-value medical devices in the near-term. Savvy investors have finally started to pay attention.

Biotricity Has The Right Pieces In the Right Places

Biotricity appears to have the pieces in place for a booming launch of its new mobile cardiac telemetry device, called Bioflux, which was just cleared for marketing by the USFDA last week. This remote EKG monitor transmits data continuously to data monitoring centers, to help in the evaluation and diagnosis of atrial fibrillation.

Bioflux is perfectly positioned to make a splash in this market because mobile, continuously transmitting monitors are a major, growing segment of cardiac monitoring; Bioflux should be ready to roll under existing reimbursement coding practices; and the company has a plan to incentivize health care providers.

For example, similar company Biotelemetry (BEAT) reports $80 Million in quarterly sales and has said that mobile cardiac out-patient telemetry devices, like Bioflux, make up a massive 70% of their current business. For a product that emerged only a few years back, that’s an incredibly quick displacement of older technology, like Event and Holter monitors, which don’t last as long and do not always transmit data remotely.

Here’s the real clincher for Biotricity: the company has also said they plan to improve economics for health care providers. This is important, as low economics for health care providers has been a hurdle for other cardiac players.

BioTelemetry said on their first quarter 2016 conference call, “The economic incentive for a physician to use this service is almost non-existent specific to the service itself. However, we have thousands of physicians that use it, because it produces a yield that nothing else is even close to, which means, [physician’s] revenue will come with follow-on procedures and inflations and implants and such…But I’d be lying if I told you that hadn’t been a barrier to growth and a challenge to growth over the years that we’ve been in the marketplace with it…”

This company, generating $80 Million in quarterly sales is admitting that physicians aren’t thrilled to be using these products because their offices don’t make much money! In short, if Biotricity can turn this commercial process on its head, and get physicians invested in using Bioflux, the upside could be tremendous.

This is not a saturated market, with only four players in real-time remote monitoring. Bioticity only needs to capture $10 to $20 Million of this market quickly to make a meaningful impact on the company’s lean income statement.

Biotricity Could Sidestep Pitfalls Where Other Medical Devices Fail

Reimbursement, or payment from insurance companies, isn’t always the first element that a company considers when developing a medical device or drug – but it should be. Biotricity has the makings of a success on this front.

Companies might assume that a medical need will ensure payment from insurers and government entities like the Centers for Medicare & Medicaid Services (CMS), but that’s not always the case. This is especially important in the age of the Affordable Care Act, where the need to reduce health care expenditures while improving healthcare outcomes means medical need alone is not always sufficient to “get paid.” About 1 in 3 Americans are covered by either Medicare or Medicaid, the government entities that cover older Americans, the disabled, and lower income individuals. They make up a huge portion of health care spending in the United States, and getting Medicare to reimburse, or pay for, a new device isn’t always easy.

Coding is the language of CMS, private insurance companies, and physicians, and it translates into payment. A “CPT” code (for Current Procedural Terminology) from the American Medical Association is a numerical code that identifies medical services and products to streamline reporting and increase accuracy and efficiency. CPT codes are how health care providers bill insurance companies and Medicare or Medicaid. Without a CPT code, no one gets paid, and this is where many companies stumble without the proper plan or codes in place for their new product or drug.

AliveCorp’s recently approved KardiaBand is a good example where the product may not find its feet, despite excitement in the press. This is the first FDA-cleared medical device accessory for Apple Watch, and it can record an EKG in 30 seconds with a touch of its integrated sensor. It’s far from the first remote EKG monitor, but it is the first to be cleared by the USFDA for use with the Apple Watch.

KardiaBand may face a major uphill battle, however, as it doesn’t have clear CPT codes in place for use with insurance companies or CMS. It may be relegated to the self-pay or consumer market, where people buy the band for their own use, not necessarily at the behest of their health care provider. The “sell” may be harder than recent headlines make it appear.

As a 3-lead monitor, Bioflux, meanwhile, can probably be reimbursed, initially, under one of a few CPT codes covering ambulatory cardiac event monitor technology or external mobile cardiac telemetry monitors, all of which have been established for years and are well understood by insurers and the Centers for Medicare & Medicaid. These are reimbursed at anywhere from $700 to $1000 per use.

With these facets in place at the time of launch, Biotricity doesn’t have to waste time or money establishing processes with insurance companies or CMS – they can sidestep the pitfalls that cause the failure of so many other new medical devices and launch straight into a willing and receptive market.

Remote Monitoring To Become Next Major Medical Revolution?

Bioflux is only Biotricity’s first product to receive FDA clearance, and the company is hinting at a rapid portfolio buildout of additional remote biometric monitors in other medical segments in the short-term. Biotricity raised $2.5 Million in a financing lead by existing investors in the days following the company’s FDA clearance. This is encouraging, seeing current investors double down at higher prices in front of the next phase of growth for the company.

But the company has also been hinting at plans to quickly expand their product portfolio into other medical segments where remote monitoring could be transformational as technology goes mainstream in health care. With Bioflux in 2017, the company has established that they can bring a device to market quickly and efficiently. With three or four devices capturing $10-$50 Million in annual revenue in a few years, BTCY could trade to multiples of its current valuation.

Rapid transformations at small companies often go unnoticed by the public markets, but once these transformations catch on they can have big impacts even on small-cap companies.

Future FinTech Group Inc. (NASDAQ: FTFT) for example announced a major technology development service contract with Reits Technology Co. to develop a shopping blockchain software system for the larger company, sending FTFT roaring during the Christmas holiday week. The same for Energous Corporation (NASDAQ: WATT) after the company received the first FCC certification for power-at-a-distance wireless charging. WATT soared by 95%!

Biotricity plans to expand their suite of biometric remote monitoring products rapidly, which is where things get truly interesting for BTCY shareholders. Diabetes care, as an example, is on the precipice of a major change as remote, rapid diagnostic devices simplify glucose monitoring, which has created huge opportunities for small companies bringing new hardware to the market. Other therapeutic areas are following suit, and 2018 should be a big year for BTCY as they launch Bioflux and begin portfolio expansion.

About One Equity Stocks

One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of BTCY, we are reimbursed for actual costs of this distribution and have received 60,000 shares of restricted stock for Business Development, Capital Markets and Research Services. We will likely receive an additional 60,000 shares of BTCY in the future. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.

SOURCE: One Equity Stocks

ReleaseID: 485030

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free research report on CNX Resources Corp. (NYSE: CNX). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CNX as the Company’s latest news hit the wire. On December 26, 2017, the Company announced that it plans to rebrand the businesses of CONE Gathering LLC, which it acquired from Noble Energy, Inc. (NYSE: NBL) on December 15, 2017. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, CNX Resources and Noble Energy most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=CNX

www.active-investors.com/registration-sg/?symbol=NBL

The Rebranding Exercise

CNX Resources plans to undertake a rebranding exercise of CONE and all the businesses acquired as a part of the transaction. Accordingly, CONE Gathering and its subsidiaries, including CONE Midstream Partners, L.P. (NYSE: CNNX) will be brought under the CNX brand. As part of this exercise, CONE Midstream Partners, L.P. will be rebranded as CNX Midstream Partners L.P. CNX Midstream Partners’ ticker is also expected to change from “CNNX” to “CNXM” once the rebranding is completed. The branding exercise will be implemented by CNX Resources once the transaction is completed, i.e. in Q1 2018.

The Acquisition

CNX Resources had acquired 50% membership interest in CONE Gathering LLC from Noble Energy for $305 million in cash. This transaction includes CONE Gathering’s interests in CONE Midstream GP, LLC. CONE Midstream has partnership interest in CONE Midstream Partners, L.P. (“CONE”) and all the incentive distribution rights in CONE. Once the transaction is completed, CNX will own 100% of CONE Gathering and CONE will transform into a single-sponsor master limited partnership. This transaction is expected to close in Q1 2018 subject to regulatory approvals and other closing conditions.

CONE Midstream Partners was formed by two sponsors – by CONSOL Energy Inc. (now CNX Resources) and Noble Energy, Inc. (NYSE: NBL). It owns, operates, and develops natural gas gathering and other midstream energy assets in the Marcellus Shale in Pennsylvania and West Virginia. Its assets include natural gas gathering pipelines and compression and dehydration facilities as well as condensate gathering, collection, separation, and stabilization facilities.

About CNX Resources Corp.

On November 28, 2017, CONSOL Energy’s coal and gas businesses were split up into two independent companies. The gas business has been named as CNX Resources Corp., while the coal business has been given the name CONSOL Energy Inc.

CNX Resources is based in Canonsburg, Pennsylvania and is one of the largest independent natural gas exploration, development, and production companies. The Company’s operations are centered in the major shale formations of the Appalachian basin. CNX had 6.3 trillion cubic feet equivalent of proved natural gas reserves at the end of December 31, 2016.

CONSOL Energy has been listed on the New York Stock Exchange (NYSE) under the “CEIX” ticker. This business unit will own, operate, and develop all the Company’s coal assets, including its interest in the Pennsylvania Mining Complex, the Baltimore Marine Terminal, and approximately one billion tons of greenfield coal reserves.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, CNX Resources’ stock dropped 2.23%, ending the trading session at $14.49.

Volume traded for the day: 2.58 million shares.

Stock performance in the last month – up 8.58%; previous three-month period – up 2.55%; and past six-month period – up 15.13%

After yesterday’s close, CNX Resources’ market cap was at $3.33 billion.

The stock is part of the Basic Materials sector, categorized under the Independent Oil & Gas industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485051

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors has a free review on CubeSmart (NYSE: CUBE) following the Company’s announcement that it will begin trading ex-dividend on December 29, 2017. In order to capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on December 28, 2017. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on CUBE:

www.active-investors.com/registration-sg/?symbol=CUBE

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On December 14, 2017, CubeSmart announced that its Board of Trustees declared a quarterly dividend of $0.30 per common share for the period ending December 31, 2017. The dividend is payable on January 16, 2018, to common shareholders of record on January 02, 2018. The quarterly distribution represents an annualized dividend rate of $1.20 per share, a $0.12 per share increase from the previous annual rate of $1.08 per share.

CubeSmart’s indicated dividend represents a yield of 4.21%, which is substantially above the average dividend yield of 3.78% for the financial sector. The Company has raised dividend for five years in a row.

Dividend Insights

CubeSmart has a dividend payout ratio of 76.4%, which indicates that the Company distributes approximately $0.76 for every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, CubeSmart is forecasted to report earnings of $0.78 for the next year compared to the Company’s annualized dividend of $1.20. One of the primary reasons for the difference between earnings and annualized dividend is that CubeSmart is a Real Estate Investment Trust (REIT), structured by law to distribute at least 90% of earnings. Moreover, since REITs generate income from owning portfolios of investment real estate, they are likely to have higher depreciation charges.

Since depreciation is a non-cash charge, it does not directly impact the ability of dividend the companies can distribute. For this reason, Fund from Operations (FFO) is calculated by adding depreciation and amortization to earnings and subtracting any gains on sales which then provides a better picture of any company’s profitability and capacity to pay and to sustain dividends. For instance, CubeSmart’s net income attributable to the Company’s common shareholders was $0.21 per share for Q3 2017 compared to $0.13 for Q3 2016. CubeSmart’s FFO per share, as adjusted, increased 10.5% to $0.42 for Q3 2017, compared to $0.38 for Q3 2016. The FFO indicates that the Company should be able to comfortably cover its dividend payout.

As of September 30, 2017, CubeSmart had cash and cash equivalents of $6.23 million compared to $2.97 million as on December 31, 2016. The Company’s strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

About CubeSmart

CubeSmart is a self-administered and self-managed real estate investment trust. The Company owns or manages 931 self-storage properties across the United States. According to the 2017 Self Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the US. The Company’s self-storage properties are designed to offer affordable, easily accessible, and, in most locations, climate-controlled storage space for residential and commercial customers.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, CubeSmart’s stock was marginally up 0.52%, ending the trading session at $29.02.

Volume traded for the day: 767.80 thousand shares.

Stock performance in the last three-month – up 12.31%; previous six-month period – up 20.77%; past twelve-month period – up 10.30%; and year-to-date – up 8.40%

After yesterday’s close, CubeSmart’s market cap was at $5.23 billion.

Price to Earnings (P/E) ratio was at 44.51.

The stock has a dividend yield of 4.14%.

The stock is part of the Financial sector, categorized under the REIT – Industrial industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485052

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free research report on Hubbell Inc. (NYSE: HUBB). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HUBB as the Company’s latest news hit the wire. On December 26, 2017, the Company declared that it has entered into a definitive agreement to acquire Aclara Technologies LLC, an affiliate of Sun Capital Partners, Inc. for approximately $1.1 billion in an all-cash transaction. The acquisition is expected to strengthen and broaden Hubbell Power Systems’ competitive position across utility markets. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Hubbell most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HUBB

Aclara, A World-Class Supplier of Smart Infrastructure Solutions

Aclara supplies smart infrastructure solutions (SIS) to water, gas, and electric utilities globally. It offers a wide range of solutions such as advanced metering infrastructure, meters and edge devices, software, and installation services. These services help utilities predict and respond to conditions, optimize network performance, leverage their distribution networks effectively and engage with their customers. Moreover, actionable insights help utilities predict, plan and respond to conditions, improve operational efficiency and promote resource conservation to customers.

At present, the Company has over 1,200 people working with more than 800 electric, water, and gas utilities worldwide. And it reported revenues of $500 million and adjusted EBITDA of $90 million for the fiscal year ended September 30, 2017.

Strategic Benefits for Hubbell

Strengthen Hubbell’s Leadership Position in Competitive Markets -The acquisition brings together complementary strengths of Aclara and Hubbell Power Systems. The addition of Aclara’s software and analytics solutions and its robust communications networks to Hubbell Power Systems’ performance-critical components will create a differentiated solution for a broad set of utility customers to meet their next gen needs. Moreover, integration of Aclara’s strong customer relationships and smart infrastructure solutions into the Hubbell’s innovative portfolio will also accelerate its ongoing innovation efforts to address utility customer demand for data and integrated solutions.

Enhances Hubbell’s smart technology and automation capabilities -Aclara’s advanced metering solutions and grid monitoring sensor technology, as well as its leading software enabled installation services, will expand Hubbell’s presence in utility automation. It will also help the Company offer an end-to-end solution to customers.

Financial Benefits -The transaction is expected to be accretive to Hubbell’s diluted EPS, excluding intangible amortization and deal related costs in 2018 and in 2019 on a GAAP basis. Moreover, Hubbell expects to maintain an investment grade rating post the acquisition.

Aclara Expects to Benefit from Joining Hubbell

Allan Connolly, President and CEO of Aclara, expressed his delight on Aclara becoming part of Hubbell, given its vast resources, alliance relationships with major utilities, and shared commitment to quality and innovation. Aclara acknowledged Sun Capital’s support towards making it a world-leading provider of end-to-end, smart infrastructure solutions for electric, water, and gas utilities. Now, the Company looks forward to a bright future with Hubbell.

Transaction Financing and Approvals

For the purpose of the transaction, Hubbell has taken fully committed bridge financing from J.P. Morgan Securities LLC, BofA Merrill Lynch, and HSBC Securities (USA). Hubbell anticipates a debt-to-adjusted EBITDA ratio of 3.1x at transaction closing, but it intends to reduce this ratio over the next few years.

The acquisition is subject to the satisfaction of customary closing conditions, including US antitrust clearance. Post which, it is expected to be completed in the first quarter of 2018.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, Hubbell’s stock dropped 1.18%, ending the trading session at $135.88.

Volume traded for the day: 299.58 thousand shares.

Stock performance in the last month – up 12.03%; previous three-month period – up 17.35%; past twelve-month period – up 14.69%; and year-to-date – up 16.44%

After yesterday’s close, Hubbell’s market cap was at $7.43 billion.

Price to Earnings (P/E) ratio was at 26.23.

The stock has a dividend yield of 2.27%.

The stock is part of the Technology sector, categorized under the Diversified Electronics industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485053

Stock Monitor: Sucampo Pharma Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 28, 2017 / Active-Investors.com has just released a free research report on Mallinckrodt PLC (NYSE: MNK). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MNK as the Company’s latest news hit the wire. On December 26, 2017, the Company, a leading global specialty pharmaceutical organization, entered into an agreement with another global biopharmaceutical Company, Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) (“Sucampo”), wherein Mallinckrodt agreed to acquire Sucampo, including its commercial and development assets. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Mallinckrodt and Sucampo Pharma most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=MNK

www.active-investors.com/registration-sg/?symbol=SCMP

Acquisition to Bring Mallinckrodt Closer to its Vision

Mallinckrodt’s acquisition of Sucampo will take it one step closer towards its vision of becoming an innovation-driven specialty pharmaceutical growth Company focused on improving outcomes for patients with severe and critical conditions. The transaction will be accretive to near-term net sales and earnings through AMITIZA® (lubiprostone) and will also boost Mallinckrodt’s pipeline in rare diseases with VTS-270 and CPP-1X/sulindac.

Mallinckrodt to Access Sucampo’s Assets

Commercial Assets

AMITIZA® (lubiprostone) is a leading global product in the branded constipation market. It is meant for the treatment of chronic idiopathic constipation (CIC) in adults; irritable bowel syndrome with constipation (IBS-C) in women 18 years of age and older; and opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain, including patients with chronic pain related to previous cancer, or its treatment which does not require frequent opioid dosage escalation. At present, the US Food and Drug Administration (FDA) is reviewing a supplemental New Drug Application (sNDA) for AMITIZA® in children 6 to 17 years of age with pediatric functional constipation (PFC). The approval is expected in the first quarter of 2018, which would make AMITIZA® the first and only approved prescription therapy available to treat children with PFC, a condition that affects about 18% of the pediatric population. Mallinckrodt will acquire global rights to the product, with reported a 2016 global net sales of $456 million.

RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is indicated for ocular hypertension and open-angle glaucoma, and is marketed in Japan. The acquisition will provide Mallinckrodt global rights to the product, with annual net sales of approximately $9 million.

Development Assets

VTS-270 is indicated for the treatment of Niemann-Pick Type C (NPC), which is a rare, neurodegenerative, and ultimately fatal disease that can occur at any age. This rare disease affects around 2,000 to 3,000 patients globally, with about 500 cases in the US alone. At present, VTS-270 is amidst its Phase-3 trial, with the NDA filing currently expected in 2018, and approval anticipated in 2019. Mallinckrodt will acquire global rights to the therapy, whose peak net sales, if approved, are estimated to be more than $150 million.

CPP-1X/sulindac is in Phase-3 development for Familial Adenomatous Polyposis (FAP) under a collaborative agreement between Cancer Prevention Pharmaceuticals (CPP) and Sucampo. If this condition is left untreated, it could result into colorectal cancer. FAP is a rare disease that affects 1 in 10,000 people with about 30,000 cases estimated in the US. The therapy is amidst its Phase-3 trial, whose completion is expected by the end of 2018. Mallinckrodt would acquire the exclusive option to obtain North American commercial rights for a nominal fee, with CPP retaining rights to the rest of the world. Peak US potential net sales for the product are estimated to be more than $300 million.

Commercialization

Mallinckrodt looks forward to bringing VTS-270 and CPP-1X/sulindac to patients with critical unmet medical needs through its sales organizations that are focused on rare diseases. Mallinckrodt’s strong relationships with insurance companies and group purchasing organizations would enhance patient access to these unique treatment options. Besides, Mallinckrodt’s existing infrastructure of clinical and medical affairs experts will also facilitate the approval and launch of both products.

Acquisition Implies Value Creation for Sucampo’s Shareholders

Sucampo is a biopharmaceutical Company that works towards the development and commercialization of highly specialized medicines. The Company aims to offer solutions for patients affected by diseases with few or no current treatment options, and to their caregivers and physicians. Peter Greenleaf, Chairman and Chief Executive Officer (CEO) of Sucampo, believes that this transaction is proof of the hard work and dedication of Sucampo’s employees, who have worked very hard for the Company to reach this stage. He also believes that this transaction with Mallinckrodt would create significant value for shareholders. It would help accelerate the development of its rare disease assets in NPC and FAP, and enhance reach of AMITIZA® to patients suffering from constipation-related disorders, through the addition of significant resources and expertise.

Total Compensation for the Transaction

As per the agreement, Sun Acquisition Co., a subsidiary of Mallinckrodt, will initiate a cash tender offer to purchase all of the outstanding shares of Sucampo’s common stock for $18.00 per share. This implies a total transaction value of approximately $1.2 billion. This amount includes anticipated payments in respect of Sucampo’s debt.

Transaction Financing

Mallinckrodt intends to fund the transaction through borrowings under its existing revolving credit facility, a new secured term loan facility, and/or cash on hand. However, it plans to utilize its significant cash generation to ease outstanding debt over time.

Financial Implications

Mallinckrodt anticipates the transaction to be accretive to adjusted diluted earnings per share of at least $0.30 in 2018, and at least double that amount in 2019, based on the assumption of a first quarter 2018 close.

However, no guidance on the impact of the acquisition on Mallinckrodt’s GAAP35 diluted earnings per share has been shared yet, due to the inherent difficulty of forecasting the timing or amount of items that would be included in calculating such an impact.

Transaction Approvals

So far, the Boards of Directors of both Companies have approved the transaction. Sucampo’s stockholders holding about 32% of the outstanding Sucampo shares have entered into a tender and support agreement for this transaction, which is subject to customary closing conditions, including expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and the tender of a majority of the outstanding Sucampo shares.

Stock Performance Snapshot

December 27, 2017 – At Wednesday’s closing bell, Mallinckrodt’s stock slightly fell 0.85%, ending the trading session at $23.28.

Volume traded for the day: 2.56 million shares.

Stock performance in the last month – up 6.99%

After yesterday’s close, Mallinckrodt’s market cap was at $2.24 billion.

The stock is part of the Healthcare sector, categorized under the Drugs – Generic industry. This sector was up 0.3% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485054